CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 
 

CASI's Net Cash Flow Growth by Quarter and Year

Casi Pharmaceuticals Inc 's Net Cash Flow results by quarter and year




CASI Net Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 8.41 -14.42 -17.53 -30.58
III Quarter September 19.84 -7.23 29.70 13.95
II Quarter June -10.40 -7.76 -9.00 -29.48
I Quarter March -9.45 11.05 0.26 15.53
FY   8.40 -18.36 3.43 -30.58



CASI Net Cash Flow fourth quarter 2022 Y/Y Growth Comment
Casi Pharmaceuticals inc in the fourth quarter 2022 achieved Net Cash Flow of $ 8.41 millions compare to net cash outflow recorded in same quarter a year ago.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 23 other companies have achieved higher Net Cash Flow growth. While Casi Pharmaceuticals Inc ' s Net Cash Flow no change of % ranks overall at the positon no. 602 in the fourth quarter 2022.




CASI Net Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - 112.9 % -57.27 %
II Quarter June - - - -
I Quarter March - 4150 % -98.33 % 142.66 %
FY   - - - -

Financial Statements
Casi Pharmaceuticals Inc 's fourth quarter 2022 Net Cash Flow $ 8.41 millions CASI's Income Statement
Casi Pharmaceuticals Inc 's fourth quarter 2021 Net Cash Flow $ -14.42 millions Quarterly CASI's Income Statement
New: More CASI's historic Net Cash Flow Growth >>


CASI Net Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December -57.62 % - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Cash Flow fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #101
Overall #602

Net Cash Flow Y/Y Growth Statistics
High Average Low
155.22 % 7.68 % -70.72 %
(Jun 30 2018)   (Mar 31 2018)
Net Cash Flow fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #101
Overall #602
Net Cash Flow Y/Y Growth Statistics
High Average Low
155.22 % 7.68 % -70.72 %
(Jun 30 2018)   (Mar 31 2018)

Net Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Casi Pharmaceuticals Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
155.22 % 7.68 % -70.72 %
(Jun 30 2018)  


CASI's IV. Quarter Q/Q Net Cash Flow Comment
In the IV. Quarter 2022 Casi Pharmaceuticals Inc realized fall in Net Cash Flow sequentially by -57.62% to $ 8.41 millions, from $ 19.84 millions achived a quarter before.

Within Major Pharmaceutical Preparations industry 23 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Casi Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is 602.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #101
Overall #602
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #24
Healthcare Sector #101
Overall #602
Net Cash Flow Q/Q Growth Statistics
High Average Low
155.22 % 7.68 % -70.72 %
(Jun 30 2018)  


CASI's IV. Quarter Q/Q Net Cash Flow Comment
In the IV. Quarter 2022 Casi Pharmaceuticals Inc realized fall in Net Cash Flow sequentially by -57.62% to $ 8.41 millions, from $ 19.84 millions declared a quarter before.

Within Major Pharmaceutical Preparations industry 23 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Casi Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is 602.


Casi Pharmaceuticals Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Cash Flow 12 Months Ending $ -14.42 $ -41.50 $ -38.86 $ -18.36 $ -21.47
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Casi Pharmaceuticals inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Casi Pharmaceuticals inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CASI's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CASI's Competitors
Net Cash Flow Growth for Casi Pharmaceuticals Inc 's Suppliers
Net Cash Flow Growth for CASI's Customers

You may also want to know
CASI's Annual Growth Rates CASI's Profitability Ratios CASI's Asset Turnover Ratio CASI's Dividend Growth
CASI's Roe CASI's Valuation Ratios CASI's Financial Strength Ratios CASI's Dividend Payout Ratio
CASI's Roa CASI's Inventory Turnover Ratio CASI's Growth Rates CASI's Dividend Comparisons



Companies with similar Net Cash Flow fall for the quarter ending Dec 31 2022 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2022
Brainsway Ltd -0.24%$ -0.236 millions
Astrazeneca Plc-2.58%$ -2.575 millions
Nuvasive Inc-3.04%$ -3.040 millions
Purple Biotech Ltd -3.17%$ -3.174 millions
Mannkind Corporation-3.54%$ -3.545 millions
Calliditas Therapeutics Ab-4.09%$ -4.095 millions
Pharming Group N v -6.45%$ -6.451 millions
China Health Industries Holdings Inc -6.68%$ -6.684 millions
Galectin Therapeutics Inc -9.42%$ -9.416 millions
Cabaletta Bio Inc -10.05%$ -10.045 millions
Silk Road Medical Inc -11.70%$ -11.702 millions
Gsk Plc-12.89%$ -12.892 millions
Valneva Se-16.52%$ -16.515 millions
Inventiva S a -18.10%$ -18.104 millions
Xtl Biopharmaceuticals Ltd -18.23%$ -18.232 millions
Actavia Life Sciences Inc -19.83%$ -19.832 millions
Marpai Inc -20.85%$ -20.848 millions
Biolinerx Ltd -22.82%$ -22.821 millions
Ascendis Pharma A-23.65%$ -23.652 millions
Innate Pharma Sa-24.15%$ -24.151 millions
Apeiron Capital Investment Corp -26.15%$ -26.147 millions
Gilead Sciences Inc -26.95%$ -26.947 millions
4d Molecular Therapeutics Inc -27.91%$ -27.912 millions
American Shared Hospital Services-27.95%$ -27.945 millions
Koninklijke Philips Nv-28.61%$ -28.611 millions
Edap Tms Sa-29.06%$ -29.064 millions
Nanobiotix S a -29.57%$ -29.568 millions
Protagenic Therapeutics Inc new-29.84%$ -29.844 millions
Nucana Plc-31.01%$ -31.013 millions
Nls Pharmaceutics Ltd -34.10%$ -34.104 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com